Phase 4Active, not recruiting
Pharmacokinetics of Transdermal Metronidazole
Impact of Formulation on the Pharmacokinetics of Micropatch-assisted Delivery of Metronidazole
- Sponsor
- University of Iowa (Academic or other)
- Enrollment
- 24 planned
- Conditions
- Healthy
- Interventions
- Metronidazole 0.75% Topical Gel; Metronidazole 0.75% Topical Cream; Transdermal water loss measurement; Electrical Resistance; Skin color measurement; Micropatch application
- Ages
- adults, older adults
- Registry
- NCT05929794
Full record on ClinicalTrials.gov
From the registry
This is a crossover pharmacokinetic clinical study in healthy volunteers to compare metronidazole delivery through skin when a gel or cream metronidazole product is applied to skin treated with a micropatch.
Primary outcomes
- Measurement of maximum serum metronidazole concentration (Cmax)
- Time of maximum serum metronidazole concentration (Tmax)
- Area under the serum-concentration curve from 0-120 hours
History
Study completion expected
Last registry update
Primary completion
Started
Registered